Copyright Reports & Markets. All rights reserved.

Global Coronary Artery Disease Therapeutics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Coronary Artery Disease Therapeutics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Beta-Blockers
      • 1.4.3 Calcium Channel Blockers
      • 1.4.4 Nitrates
      • 1.4.5 ACE Inhibitors
      • 1.4.6 Others
    • 1.5 Market by Application
      • 1.5.1 Global Coronary Artery Disease Therapeutics Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Coronary Artery Disease Therapeutics Market Size
    • 2.2 Coronary Artery Disease Therapeutics Growth Trends by Regions
      • 2.2.1 Coronary Artery Disease Therapeutics Market Size by Regions (2014-2025)
      • 2.2.2 Coronary Artery Disease Therapeutics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Coronary Artery Disease Therapeutics Market Size by Manufacturers
      • 3.1.1 Global Coronary Artery Disease Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Coronary Artery Disease Therapeutics Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Coronary Artery Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Coronary Artery Disease Therapeutics Key Players Head office and Area Served
    • 3.3 Key Players Coronary Artery Disease Therapeutics Product/Solution/Service
    • 3.4 Date of Enter into Coronary Artery Disease Therapeutics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Coronary Artery Disease Therapeutics Market Size by Type (2014-2019)
    • 4.2 Global Coronary Artery Disease Therapeutics Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Coronary Artery Disease Therapeutics Market Size (2014-2019)
    • 5.2 Coronary Artery Disease Therapeutics Key Players in United States
    • 5.3 United States Coronary Artery Disease Therapeutics Market Size by Type
    • 5.4 United States Coronary Artery Disease Therapeutics Market Size by Application

    6 Europe

    • 6.1 Europe Coronary Artery Disease Therapeutics Market Size (2014-2019)
    • 6.2 Coronary Artery Disease Therapeutics Key Players in Europe
    • 6.3 Europe Coronary Artery Disease Therapeutics Market Size by Type
    • 6.4 Europe Coronary Artery Disease Therapeutics Market Size by Application

    7 China

    • 7.1 China Coronary Artery Disease Therapeutics Market Size (2014-2019)
    • 7.2 Coronary Artery Disease Therapeutics Key Players in China
    • 7.3 China Coronary Artery Disease Therapeutics Market Size by Type
    • 7.4 China Coronary Artery Disease Therapeutics Market Size by Application

    8 Japan

    • 8.1 Japan Coronary Artery Disease Therapeutics Market Size (2014-2019)
    • 8.2 Coronary Artery Disease Therapeutics Key Players in Japan
    • 8.3 Japan Coronary Artery Disease Therapeutics Market Size by Type
    • 8.4 Japan Coronary Artery Disease Therapeutics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Coronary Artery Disease Therapeutics Market Size (2014-2019)
    • 9.2 Coronary Artery Disease Therapeutics Key Players in Southeast Asia
    • 9.3 Southeast Asia Coronary Artery Disease Therapeutics Market Size by Type
    • 9.4 Southeast Asia Coronary Artery Disease Therapeutics Market Size by Application

    10 India

    • 10.1 India Coronary Artery Disease Therapeutics Market Size (2014-2019)
    • 10.2 Coronary Artery Disease Therapeutics Key Players in India
    • 10.3 India Coronary Artery Disease Therapeutics Market Size by Type
    • 10.4 India Coronary Artery Disease Therapeutics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Coronary Artery Disease Therapeutics Market Size (2014-2019)
    • 11.2 Coronary Artery Disease Therapeutics Key Players in Central & South America
    • 11.3 Central & South America Coronary Artery Disease Therapeutics Market Size by Type
    • 11.4 Central & South America Coronary Artery Disease Therapeutics Market Size by Application

    12 International Players Profiles

    • 12.1 Pfizer
      • 12.1.1 Pfizer Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Coronary Artery Disease Therapeutics Introduction
      • 12.1.4 Pfizer Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
      • 12.1.5 Pfizer Recent Development
    • 12.2 Novartis
      • 12.2.1 Novartis Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Coronary Artery Disease Therapeutics Introduction
      • 12.2.4 Novartis Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
      • 12.2.5 Novartis Recent Development
    • 12.3 GlaxoSmithKline
      • 12.3.1 GlaxoSmithKline Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Coronary Artery Disease Therapeutics Introduction
      • 12.3.4 GlaxoSmithKline Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
      • 12.3.5 GlaxoSmithKline Recent Development
    • 12.4 Merck
      • 12.4.1 Merck Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Coronary Artery Disease Therapeutics Introduction
      • 12.4.4 Merck Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
      • 12.4.5 Merck Recent Development
    • 12.5 AstraZeneca
      • 12.5.1 AstraZeneca Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Coronary Artery Disease Therapeutics Introduction
      • 12.5.4 AstraZeneca Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
      • 12.5.5 AstraZeneca Recent Development
    • 12.6 Gilead
      • 12.6.1 Gilead Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Coronary Artery Disease Therapeutics Introduction
      • 12.6.4 Gilead Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
      • 12.6.5 Gilead Recent Development
    • 12.7 Bayer
      • 12.7.1 Bayer Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Coronary Artery Disease Therapeutics Introduction
      • 12.7.4 Bayer Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
      • 12.7.5 Bayer Recent Development
    • 12.8 Bristol-Myers Squibb
      • 12.8.1 Bristol-Myers Squibb Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Coronary Artery Disease Therapeutics Introduction
      • 12.8.4 Bristol-Myers Squibb Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
      • 12.8.5 Bristol-Myers Squibb Recent Development
    • 12.9 Mylan
      • 12.9.1 Mylan Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Coronary Artery Disease Therapeutics Introduction
      • 12.9.4 Mylan Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
      • 12.9.5 Mylan Recent Development
    • 12.10 Teva Pharmaceutical Industries
      • 12.10.1 Teva Pharmaceutical Industries Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Coronary Artery Disease Therapeutics Introduction
      • 12.10.4 Teva Pharmaceutical Industries Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
      • 12.10.5 Teva Pharmaceutical Industries Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Coronary artery disease (CAD), also known as ischemic heart disease (IHD), refers to a group of diseases which includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death.
      Our research analysis on the global coronary artery disease therapeutics market has identified that the increase in number of chronic diseases will be one of the major factors that will have a positive impact on this market’s growth during the next few years.
      The consumption of drugs for cardiovascular disease (CAD) in the Americas is increasing due to the rising incidences of heart disease in the region. The region is heavily investing in the healthcare sector, which in turn, will drive the coronary artery disease therapeutics market’s growth in the region. The US is the major revenue generator in the region due to the presence of the pharmaceutical giants and high prevalence rate of CAD.
      In 2018, the global Coronary Artery Disease Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Coronary Artery Disease Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Coronary Artery Disease Therapeutics development in United States, Europe and China.

      The key players covered in this study
      Pfizer
      Novartis
      GlaxoSmithKline
      Merck
      AstraZeneca
      Gilead
      Bayer
      Bristol-Myers Squibb
      Mylan
      Teva Pharmaceutical Industries

      Market segment by Type, the product can be split into
      Beta-Blockers
      Calcium Channel Blockers
      Nitrates
      ACE Inhibitors
      Others

      Market segment by Application, split into
      Hospitals
      Clinics
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Coronary Artery Disease Therapeutics status, future forecast, growth opportunity, key market and key players.
      To present the Coronary Artery Disease Therapeutics development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Coronary Artery Disease Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now